APOE polymorphisms and cognitive functions in patients with brain tumors
- PMID: 24944262
- PMCID: PMC4115606
- DOI: 10.1212/WNL.0000000000000617
APOE polymorphisms and cognitive functions in patients with brain tumors
Abstract
Objective: The goal of this study was to assess whether the APOE ε4 allele and other APOE single nucleotide polymorphisms (SNPs) influence neuropsychological and neuroimaging outcomes in patients with brain tumors.
Methods: Two hundred eleven patients with brain tumors participated in the study. All patients completed standardized neuropsychological tests and provided a blood sample for APOE genotyping. Ratings of white matter abnormalities were performed on MRI scans. Patients were classified into 2 groups based on the presence (n = 50) or absence (n = 161) of at least one APOE ε4 allele. Additional APOE SNPs were genotyped in a subset of 150 patients.
Results: Patients with at least one APOE ε4 allele had significantly lower scores in verbal learning and delayed recall, and marginally significant lower scores in executive function, in comparison to noncarriers of an ε4 allele. Patients with at least one ε4 allele and history of cigarette smoking had significantly higher scores in working memory and verbal learning than ε4 carriers who never smoked. Nine additional APOE SNPs were significantly associated with attention and executive and memory abilities. There were no significant differences between ε4 carriers and noncarriers on the extent of white matter abnormalities on MRI.
Conclusions: The findings suggest that patients with brain tumors who are carriers of the APOE ε4 allele may have increased vulnerability to developing memory and executive dysfunction, and that additional SNPs in the APOE gene may be associated with cognitive outcome.
© 2014 American Academy of Neurology.
Figures
Comment in
-
Comment: can APOE genotyping predict cognitive damage from brain tumor therapy?Neurology. 2014 Jul 22;83(4):326. doi: 10.1212/WNL.0000000000000632. Epub 2014 Jun 18. Neurology. 2014. PMID: 24944258 No abstract available.
References
-
- Correa DD. Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep 2010;10:232–239 - PubMed
-
- Behin A, Delattre JY. Neurologic sequelae of radiotherapy on the nervous system. In: Schiff D, Wen PY, editors. Cancer Neurology in Clinical Practice. Totowa, NJ: Humana Press; 2003:173–191
-
- Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996;47:387–400 - PubMed
-
- Richard F, Amouyel P. Genetic susceptibility factors for Alzheimer’s disease. Eur J Pharmacol 2001;412:1–12 - PubMed
-
- Jordan BD. Genetic influences on outcome following traumatic brain injury. Neurochem Res 2007;32:905–915 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous